Resona Asset Management’s Moderna MRNA Stock Holding History

Resona Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$370K	Buy	5,311 +473	+10%	+$24.5K	﹤0.01%	711
2026 Q1	$233K	Buy	4,838 +408	+9%	+$19K	﹤0.01%	723
2025 Q4	$138K	Buy	4,430 +726	+20%	+$19.7K	﹤0.01%	761
2025 Q3	$93.8K	Sell	3,704 -204	-5%	-$5.69K	﹤0.01%	786
2025 Q2	$106K	Sell	3,908 -98,778	-96%	-$2.6M	﹤0.01%	788
2025 Q1	$2.95M	Buy	102,686 +7,933	+8%	+$282K	0.02%	549
2024 Q4	$3.92M	Sell	94,753 -3,830	-4%	-$183K	0.02%	510
2024 Q3	$6.57M	Sell	98,583 -449	-0.5%	-$41.2K	0.04%	399
2024 Q2	$11.8M	Sell	99,032 -6,602	-6%	-$835K	0.07%	260
2024 Q1	$11.3M	Buy	+105,634	New	+$10.6M	0.07%	281

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Resona Asset Management's MRNA Position: Q2 2026 in Review

Resona Asset Management increased its Moderna (MRNA) stake by 9.8% in Q2 2026, buying an estimated $24.5K and bringing the position to 5,311 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

Resona Asset Management first reported a position in MRNA in Q1 2024 and has held it in 10 quarters since. The position peaked at $11.8M in Q2 2024. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Resona Asset Management held 5,311 shares of Moderna worth $370K as of Q2 2026.
Resona Asset Management bought 473 Moderna shares in Q2 2026, an estimated $24.5K.
Moderna made up ﹤0.01% of Resona Asset Management's portfolio in Q2 2026, its #711 holding.
Resona Asset Management first reported a position in Moderna in Q1 2024 and has held it in 10 quarters since.
Resona Asset Management's Moderna position peaked at $11.8M in Q2 2024.
777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.